Treatment Response in Pediatric Pulmonary Tuberculosis-A Prospective Longitudinal Study

Area of Science:

• Pediatrics
• Infectious Diseases
• Respiratory Medicine

Background:

• Limited data exist on symptom and sign resolution in pediatric pulmonary tuberculosis (PTB).
• Understanding resolution differences between PTB and other lower respiratory tract infections (LRTIs) in children is crucial.

Purpose of the Study:

• To investigate the resolution of symptoms and signs in children treated for PTB.
• To compare the resolution patterns between PTB and other LRTIs in pediatric patients.

Main Methods:

• A prospective study enrolled children (≤15 years) with suspected PTB.
• Clinical, microbiological, and radiological data were collected, with symptom/sign assessment at 1, 3, and 6 months.
• Participants were categorized into confirmed PTB, unconfirmed PTB, and unlikely PTB (other LRTIs) using NIH consensus definitions.

Main Results:

• Of 2019 children, 21% had confirmed PTB. Most common symptoms like cough and loss of appetite resolved rapidly (within 3 months).
• Persistent tachypnea (57%) and abnormal auscultatory findings (28%) were observed at 3 months.
• HIV infection and abnormal baseline chest radiography predicted symptom/sign persistence at 3 months.

Conclusions:

• Symptoms in children with PTB generally resolved quickly, while physical signs showed slower resolution.
• The pattern and speed of symptom/sign resolution did not reliably distinguish pediatric PTB from other LRTIs.